With easy access to medical information on the Internet, increased personal wealth, and longer life expectancy, consumers now have more options than ever for medical treatment. Demand for new products is high, and pharmaceutical companies are under intense pressure to be first to market.
To be first, companies must dramatically reduce drug development cycles while containing and reducing operational costs and complying with stringent regulatory controls.
Business Objects pharmaceutical industry solutions
Business Objects business intelligence (BI) solutions enable our customers to support faster and more cost-effective innovation, work more efficiently with collaborative partners, and produce and deliver products more effectively.
We help companies in the pharmaceutical industry:
- Identify the products that yield the most appropriate results with a clinical trial research process that segments, tracks, analyzes, and shares test results
- Maximize the supply chain by sharing production information with suppliers, tracking product quality, optimizing stock replenishment, and monitoring vendor performance
- Optimize campaign creation and implementation by analyzing the effectiveness of marketing strategies
- Increase sales productivity by understanding sales activities, territory, and representative performances, and by providing customized data access to ensure that customer relationship management goals are met and exceeded
Our pharmaceutical industry customers
|
|
Learn More
Find out about Business Objects consulting services. We deliver results to end users in months—not years.
For more information about solutions for the pharmaceutical industry, contact a Business Objects sales or services representative or one of our global offices.
Take Action
- Talk to a sales rep
U.S. and Canada:
+1 866 681 3435
Europe:
00800 55 11 55 11
Global contact list - Request more information
News
Resources
- Business Intelligence Across the Organization
Four reasons why BI standardization is critical
- PDF 536KB - How to Increase Market Share and Profitability in a Downturn Economy
- PDF